CD8A and plasma cell myeloma: Besides its increased potency and longer half-life compared with native IL-15 [11], IL-15SA/IL-15RαSu-Fc was shown to induce innate memory CD8+ T cells capable of non-antigen–specific killing in murine myeloma models [14, 16].